Gabe S. Sonke | Scholar Profiles and Rankings

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
EBCC-14 manifesto: Addressing disparities in access to innovation for patients with metastatic breast cancer across Europe (journal article) Ignatiadis, Michail \| Poulakaki, Fiorita \| Spanic, Tanja \| Brain, Etienne \| Lacombe, Denis \| Sonke, Gabe S. \| Vincent-Salomon, Anne \| Van Duijnhoven, Frederieke \| Meattini, Icro \| Kaidar-Person, Orit \| ... \| Cameron, David European Journal of Cancer, volume 207 (2024). 10.1016/j.ejca.2024.114156 Cite \| Source
Tumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With Chemotherapy (journal article) Geurts, Veerle C. M. \| Balduzzi, Sara \| Steenbruggen, Tessa G. \| Linn, Sabine C. \| Siesling, Sabine \| Badve, Sunil S. \| DeMichele, Angela \| Ignatiadis, Michail \| Leon-Ferre, Roberto A. \| Goetz, Matthew P. \| ... \| Kok, Marleen JAMA Oncology (2024). 10.1001/jamaoncol.2024.1917 Cited by (1) \| Cite \| Source
High expression of phosphoglycerate dehydrogenase predicts poor outcome in patients with high-grade serous ovarian cancer (journal article) van Wagensveld, Lilian \| Van Nyen, Tom \| Annibali, Daniela \| Sonke, Gabe S \| Kruitwagen, Roy F P M \| Amant, Frederic \| Horlings, Hugo M The Oncologist (2024). 10.1093/oncolo/oyae161 Cite \| Source
Cognitive function in patients with HR+ advanced breast cancer treated with endocrine therapy with or without CDK4/6 inhibitors in the SONIA trial. (journal article) Luijendijk, Maryse \| Lee Meeuw Kjoe, Philippe \| Wortelboer, Noor \| Van Ommen - Nijhof, Annemiek \| Agelink van Rentergem, Joost \| Vermeulen, Ivar \| Konings, Inge \| Jager, Agnes \| Sonke, Gabe S. \| Van Der Wall, Elsken \| Schagen, Sanne B. Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 1016-1016 (2024). 10.1200/JCO.2024.42.16_suppl.1016 Cite \| Source
On-treatment (tx) dynamic circulating tumor DNA changes (∆ctDNA) associated with progression-free survival (PFS) and overall survival (OS) of patients (pts) with HR+/HER2− advanced breast cancer (ABC) in MONALEESA-3 (ML-3). (journal article) Chia, Stephen K. L. \| Solovieff, Nadia \| Joshi, Mukta \| Im, Seock-Ah \| Bianchi, Giulia Valeria \| de la Cruz-Merino, Luis \| Jerusalem, Guy Heinrich Maria \| Sonke, Gabe S. \| Nusch, Arnd \| Beck, J. Thaddeus \| ... \| Neven, Patrick Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 1012-1012 (2024). 10.1200/JCO.2024.42.16_suppl.1012 Cite \| Source
Oncologic outcome of response-guided axillary treatment in patients with cN1 breast cancer after primary systemic therapy. (journal article) van Hemert, Annemiek \| van Loevezijn, Ariane \| Baas, Marie-Sophie \| Stokkel, Marcel P \| Groen, Emilie \| van der Noort, Vincent \| Loo, Claudette \| Sonke, Gabe S. \| Russell, Nicola \| van Duijnhoven, Frederieke H \| Vrancken Peeters, Marie-Jeanne T.F.D Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 514-514 (2024). 10.1200/JCO.2024.42.16_suppl.514 Cite \| Source
Effects of physical exercise during adjuvant chemotherapy for breast cancer on long-term tested and perceived cognition: results of a pragmatic follow-up study (journal article) Naaktgeboren, Willeke R. \| Koevoets, Emmie W. \| Stuiver, Martijn M. \| van Harten, Wim H. \| Aaronson, Neil K. \| van der Wall, Elsken \| Velthuis, Miranda \| Sonke, Gabe \| Schagen, Sanne B. \| Groen, Wim G. \| May, Anne M. Breast Cancer Research and Treatment, volume 205, issue 1, pages 75-86 (2024). 10.1007/s10549-023-07220-7 Cite \| Source
Gray oncologic areas (journal article) Buiting, Hilde M. \| Sonke, Gabe S. Journal of Surgical Oncology, volume 129, issue 6, pages 1013-1014 (2024). 10.1002/jso.27598 Cite \| Source
Effect of Physical Exercise on MRI ‐Assessed Brain Perfusion in Chemotherapy‐Treated Breast Cancer Patients: A Randomized Controlled Trial (journal article) Koevoets, Emmie W. \| Petr, Jan \| Monninkhof, Evelyn M. \| Geerlings, Mirjam I. \| Witlox, Lenja \| van der Wall, Elsken \| Stuiver, Martijn M. \| Sonke, Gabe S. \| Velthuis, Miranda J. \| Jobsen, Jan J. \| ... \| Schagen, Sanne B. Journal of Magnetic Resonance Imaging, volume 59, issue 5, pages 1667-1680 (2024). 10.1002/jmri.28967 Cited by (2) \| Cite \| Source
Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade (journal article) Liefaard, M. C. \| van der Voort, A. \| van Seijen, M. \| Thijssen, B. \| Sanders, J. \| Vonk, S. \| Mittempergher, L. \| Bhaskaran, R. \| de Munck, L. \| van Leeuwen-Stok, A. E. \| ... \| Sonke, G. S. npj Breast Cancer, volume 10, issue 1 (2024). 10.1038/s41523-024-00636-4 Cited by (1) \| Cite \| Source
Natural (journal article) Buiting, Hilde M. \| Sonke, Gabe S. Journal of Surgical Oncology (2024). 10.1002/jso.27628 Cite \| Source
Omission of axillary lymph node dissection in cN2-3 breast cancer patients with an excellent response on primary systemic treatment is safe: 4-year oncologic outcome of the MARI protocol (journal article) van Hemert, A. \| van Loevezijn, A.A. \| Baas, M.S.P.D. \| Stokkel, M.P.M. \| Groen, E. \| Loo, C. \| van der Noort, V. \| Sonke, G.S. \| Russell, N.S. \| van Duijnhoven, F.H. \| Vrancken Peeters, M.J.T.F.D. European Journal of Cancer, volume 200 (2024). 10.1016/j.ejca.2024.113618 Cited by (1) \| Cite \| Source
The INFLUENCE 3.0 model: time-dependent risks of locoregional recurrence and contralateral breast cancer, now also including patients treated with neoadjuvant systemic therapy (journal article) van Maaren, M. \| Hueting, T. \| van Uden, D. \| van Hezewijk, M. \| de Munck, L. \| Zeillemaker, A. \| Schmidt, M. \| Sonke, G. \| Groothuis-Oudshoorn, C. \| Siesling, S. European Journal of Cancer, volume 200 (2024). 10.1016/j.ejca.2024.113672 Cite \| Source
Lessons learned from postmarketing withdrawals of expedited approvals for oncology drug indications (journal article) Koole, Simone N \| Huisman, Atse H \| Timmers, Lonneke \| Westgeest, Hans M \| van Breugel, Edwin \| Sonke, Gabe S \| van Waalwijk van Doorn-Khosrovani, Sahar Barjesteh The Lancet Oncology, volume 25, issue 3, pages e126-e135 (2024). 10.1016/S1470-2045(23)00592-2 Cited by (2) \| Cite \| Source
492 Significant reduction in stoma formation rate after introduction of HIPEC as standard practice for ovarian cancer in the Netherlands (conference) Lot Aronson, S \| Belt, Alissa \| Driel, Willemien JVan \| Dorst, Eleonora BLVan \| Sonke, Gabe S \| Schreuder, Henk WR ESGO 2024 Congress Abstracts (2024) 10.1136/ijgc-2024-ESGO.656 Cite \| Source
Oligometastases: Incorporate the patient perspective to ensure optimal treatment and care (journal article) Buiting, Hilde M. \| van der Linden, Yvette \| Steenbruggen, Tessa G. \| Bolt, Eva E. \| van Houdt, Winan \| Sonke, Gabe S. Journal of Surgical Oncology, volume 129, issue 4, pages 679-680 (2024). 10.1002/jso.27561 Cited by (1) \| Cite \| Source
Intrinsic Subtype and Overall Survival of Patients with Advanced HR+/HER2− Breast Cancer Treated with Ribociclib and ET: Correlative Analysis of MONALEESA-2, -3, -7 (journal article) Prat, Aleix \| Solovieff, Nadia \| André, Fabrice \| O'Shaughnessy, Joyce \| Cameron, David A. \| Janni, Wolfgang \| Sonke, Gabe S. \| Yap, Yoon-Sim \| Yardley, Denise A. \| Partridge, Ann H. \| ... \| Carey, Lisa A. Clinical Cancer Research, volume 30, issue 4, pages 793-802 (2024). 10.1158/1078-0432.CCR-23-0561 Cited by (3) \| Cite \| Source
Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy in Patients With Advanced Ovarian Cancer (OVHIPEC-1): Final Survival Analysis of a Randomised, Controlled, Phase 3 Trial (journal article) Aronson, S. Lot \| Lopez-Yurda, Marta \| Koole, Simone N. \| Schagen van Leeuwen, Jules H. \| Schreuder, Hendrik W.R. \| Hermans, Ralph H.M. \| de Hingh, Ignace H.J.T. \| van Gent, Mignon D.J.M. \| Arts, Henriëtte J.G. \| van Ham, Maaike A.P.C. \| ... \| van Driel, Willemien J. Obstetrical & Gynecological Survey, volume 79, issue 2, pages 96-98 (2024). 10.1097/01.ogx.0001008536.08634.9f Cite \| Source
Confirmation of the utility of the CA-125 elimination rate (KELIM) as an indicator of the chemosensitivity in advanced-stage ovarian cancer in a “real-life setting” (journal article) van Wagensveld, Lilian \| Colomban, Olivier \| van der Aa, Maaike A. \| Freyer, Gilles \| Sonke, Gabe S. \| Kruitwagen, Roy F.P.M. \| You, Benoit Journal of Gynecologic Oncology, volume 35, issue 3 (2024). 10.3802/jgo.2024.35.e34 Cited by (2) \| Cite \| Source
Gene expression profiles in clinically T1-2N0 ER+HER2− breast cancer patients treated with breast-conserving therapy: their added value in case sentinel lymph node biopsy is not performed (journal article) van Roozendaal, L. M. \| Vane, M. L. G. \| Colier, E. \| Strobbe, L. J. A. \| de Boer, M. \| Sonke, G. \| Van Maaren, M. C. \| Smidt, M. L. Breast Cancer Research and Treatment, volume 203, issue 1, pages 103-110 (2024). 10.1007/s10549-023-07128-2 Cite \| Source